Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
27 12월 2023 - 6:10AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of December 2023
Commission
File Number: 001-41661
JIN
MEDICAL INTERNATIONAL LTD.
(Exact
name of registrant as specified in its charter)
No.
33 Lingxiang Road, Wujin District
Changzhou
City, Jiangsu Province
People’s
Republic of China
(Address
of Principal Executive Office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Resignation
of Jing Chen as Chairman of Audit Committee and Board Member
On
December 21, 2023, Jing Chen, the chairperson of the audit committee and an independent director of Jin Medical International Ltd. (the
“Company”), resigned from her positions with the Company, effective as of such date. The resignation of Jing Chen was not
related to any disagreement with the Company’s accounting policies.
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
JIN MEDICAL INTERNATIONAL LTD. |
|
|
|
Date:
December 26, 2023 |
By: |
/s/
Erqi Wang |
|
|
Erqi
Wang |
|
|
Chief
Executive Officer |
2
Jin Medical (NASDAQ:ZJYL)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Jin Medical (NASDAQ:ZJYL)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024